Reply to Drs Henderson and Vale [19]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 3, 2007, Pages 322-325

  Wisner, Katherine L ^a   Sit, Dorothy K Y ^a   Hanusa, Barbara H ^a   Moses Kolko, Eydie L ^a   Perel, James M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BREAST FEEDING; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; PILOT STUDY; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RATING SCALE; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 34248573936     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000270076.61887.e5     Document Type: Letter

References (16)

1. Wisner KL, Hanusa BH, Perel JM, et al. Postpartum depression: a randomized trial of sertraline vs. nortriptyline. J Clin Psychopharmacol. 2006;26:353-360.
2. Wisner KL, Perel JM, Foglia JP. Serum clomipramine and metabolite levels in four nursing mother-infant pairs. J Clin Psychiatry. 1995;56:17-20.
3. Wisner KL, Peindl KS, Gigliotti T, et al. Obsessions and compulsions in women with postpartumdepression. J Clin Psychiatry. 1999;60:176-180.
4. Uguz F, Akman C, Kaya N, et al. Postpartum onset obsessive compulsive disorder: incidence, clinical features and related factors. J Clin Psychiatry. 2007;68(1):132-138.
5. Van der Does AJ. The effects of tryptophan depletion on mood and psychiatric symptoms. J Affect Disord. 2001;64(2-3):107-119.
6. Hollander E. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder. J Clin Psychiatry. 1999;60(suppl 15):38-44.
7. Thase ME. How should efficacy be evaluated in randomized clinical trials of treatments for depression? J Clin Psychiatry. 1999;60(suppl 4):23-31.
8. Simon GE. Evidence review: efficacy and effectiveness of antidepressant treatment in primary care. Gen Hosp Psychiatry. 2002;24:213-224.
9. Gregoire AJ, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. [see comment] Lancet. 1996;347(9006):930-933.
10. Bloch M, Schmidt P, Danaceau M, et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000;157:924-930.
11. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evidence Report/Technology Assessment No. 119. Prepared by the RTI-University of North Carolina Evidence-Based Practice Center, under contract 290-02-0016. AHRQ Publication No. 05-E006-2. Rockville, MD: Agency for Healthcare Research and Quality. February 2005.
12. Wisner KL, Zarin DA, Holmboe ES, et al. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry. 2000;157:1933-1940.
13. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579-587.
14. Moses-Kolko E, Bogen D, Perel J, et al. Neonatal signs after in utero SRI exposure: literature review and clinical application. JAMA. 2005;293:2372-2382.
15. Bonari L, Pinto N, Ahn E, et al. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry. 2004;49:726-735.
16. Wisner KL, Chambers CH, Sit DK. A major public health problem in search of a definition: postpartum depression. JAMA. 2006;296:2616-2618.